When did Trevi Therapeutics, Inc. report Q4 2024 earnings?

Trevi Therapeutics, Inc. (TRVI) reported Q4 2024 earnings on March 18, 2025 after market close.

What were Trevi Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Trevi Therapeutics, Inc. reported eps of $-0.11 for Q4 2024.

Did Trevi Therapeutics, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.12 by $0.01.

Where can I find Trevi Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-041194) directly on SEC EDGAR. The filing index links above go to sec.gov.

Trevi Therapeutics, Inc. TRVI Q4 2024 Annual earnings

Reported March 18, 2025 · After market close

EPS-$0.11Beat by $0.01

EPS estimate-$0.12

Next report

Aug 6, 2026 (In 1 week)

EPS estimate-$0.11

Financials

Q4 2024

Income statement

See full

Operating income-$12.2M-37.1%

Net income-$11.4M-46.0%

EPS (diluted)-$0.11-37.5%

Balance sheet

See full

Cash & equivalents$34.1M+5.2%

Total debt$1.1M-27.2%

Total equity$99.6M+20.7%

Total assets$110.9M+24.0%

Cash flow

See full

Operating cash flow-$9.6M-50.2%

CapEx$7.0K-68.2%

Free cash flow-$9.6M-49.8%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$368.19M+176%

Enterprise value$335.15M+227%

Returns & leverage

See full

Return on equity-52.6%+135pp

Debt / equity0×0.0×

Current ratio10.4×-4.6×

Versus estimates

Diluted EPS

Q1 2026-$0.09Miss by $0.02 Q4 2025-$0.06Beat by $0.04 Q3 2025-$0.08Beat by $0.02 Q2 2025-$0.09Beat by $0.01 Q1 2025-$0.09Beat by $0.04

Q4 2024-$0.11Beat by $0.01

Ask the moment Trevi Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Trevi Therapeutics, Inc. report Q4 2024 earnings?: Trevi Therapeutics, Inc. (TRVI) reported Q4 2024 earnings on March 18, 2025 after market close.
What were Trevi Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Trevi Therapeutics, Inc. reported eps of $-0.11 for Q4 2024.
Did Trevi Therapeutics, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.12 by $0.01.
Where can I find Trevi Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-041194) directly on SEC EDGAR. The filing index links above go to sec.gov.